Synerx

SynerX Pharma was a specialty pharmaceutical company focused on the development and commercialization of generic and branded pharmaceutical products, with a particular emphasis on complex dosage forms. The company specialized in high-barrier-to-entry products, including injectable, ophthalmic, and oral liquid formulations. SynerX utilized a lean business model, leveraging strategic partnerships for manufacturing and distribution while maintaining internal expertise in regulatory affairs and product development. In 2011, the company was acquired by Perrigo to bolster its portfolio of generic extended-topical and specialty off-patent medications.